ECTRIMS 2025 – Insight into the latest MS research

02:46 Overview of the ECTRIMS conference highlights

04:03 Brett’s insights on MS research

08:29 Key research highlights from ECTRIMS 2025

16:37 Emerging treatments and therapies for MS

25:11 The role of viruses in MS

29:33 Lifestyle modifications and rehabilitation in MS

32:59 Biomarkers and their importance in MS

38:09 Engaging the MS community in research

43:48 Karen’s perspective as a person living with MS and researcher

55:04 Epstein-Barr Virus

56:37 T-cell therapy

01:00:00 MS diets

01:01:22 Myelin repair, symptoms and progression

01:04:32 Medication for Secondary Progressive MS

01:12:56 Treatments for menopause

Alex Holden Alex joined the Overcoming MS charity as Chief Executive Officer (CEO) in 2023. She has over 20 years’ experience across the voluntary and corporate sector, previously as Deputy CEO at Target Ovarian Cancer. Alex has worked in the UK, Scandinavia and Australia for organisations as diverse as Mencap, Bupa, Virgin Media, Westpac Bank and GE. She has also held voluntary roles as a trustee for the Twins Trust, a member of NCT’s Voluntary Income Advisory Group, and is currently a trustee for Hitchin Girls’ School in the UK.

Karen Campbell Karen Campbell, RN, PHD, is a registered nurse and Assistant Professor at York University in Toronto, Canada. She is both an MS researcher and was an Overcoming MS volunteer Ambassador in Toronto from 2018 – 2022 and has been following the Overcoming MS Program since 2016. Karen attended the ECTRIMS Conference this year as well as the Patient Information Day.

Brett Drummond Brett has more than 15 years experience in MS research, having pursued graduate and post-graduate studies as a laboratory scientist at the University of Melbourne. MStranslate was developed as a result of Brett’s desire to continue contributing to the MS community beyond his work as a scientist. His knowledge of MS and his talent for science communication has been recognised worldwide. Since 2022, this recognition has included his appointment as host of the official European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) podcast series and facilitator of the ECTRIMS Patient Information Day.